Ivermectin versus benzyl benzoate applied once or twice to treat human scabies in Dakar, Senegal: A randomized controlled trial

Bulletin of the World Health Organization

Volumn 87, Issue 6, 2009, Pages 424-430

  Ly, Fatimata ^a   Caumes, Eric ^b   Ndaw, Cheick Ahmet Tidiane ^c   Ndiaye, Bassirou ^d   Mahé, Antoine ^a  

^a Institut dHygiene Sociale Dakar   (Senegal)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (Senegal)

^d Centre Hospitalier Universitaire Aristide Le Dantec de Dakar   (Senegal)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYL BENZOATE; IVERMECTIN;

COMMUNITY COMPOSITION; DISEASE CONTROL; DISEASE TREATMENT; DRUG; GROUP SELECTION; HEALTH SERVICES; INFECTIOUS DISEASE; LESION; SKIN DISORDER;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SCABIES; SENEGAL; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; BENZOATES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IVERMECTIN; MALE; MIDDLE AGED; SCABIES; SENEGAL; YOUNG ADULT;

AFRICA; DAKAR [SENEGAL]; SENEGAL; SUB-SAHARAN AFRICA; WEST AFRICA;

BACTERIA (MICROORGANISMS);

EID: 67649223633     PISSN: 00429686     EISSN: 15640604     Source Type: Journal    
DOI: 10.2471/BLT.08.052308     Document Type: Article

References (21)

1. Chosidow O. Clinical practice. Scabies. N Engl J Med 2006;354:1718-1727 PMID:16625010 doi:10.1056/NEJMcp052784
2. Epidemiology and management of common skin diseases in children in developing countries. Geneva: World Health Organization; 2005. Available from: http://www.who.int/child-adolescent-health/documents/ fch-cah-05-12/en/index. html [accessed on 12 March 2009].
3. The current evidence for the burden of group A streptococcal diseases. Geneva: World Health Organization; 2005. Available from: http://www.who.int/ child-adolescent-health/documents/ fch-cah-05-07/en/ [accessed on 12 March 2009].
4. Mulholland EK, Ogunlesi OO, Adegbola RA, Weber M, Sam BE, Palmer A, et al. Etiology of serious infections in young Gambian infants. Pediatr Infect Dis J 1999;18:S35-41. PMID:10530572 doi:10.1097/00006454-199910001-200000007 (Pubitemid 29485355)
5. Walker GJ, Johnston PW. Interventions for treating scabies. Cochrane Database Syst Rev 2000;3:CD000320. PMID:10908470
6. Mahé A, Faye O, N'Diaye HT, Ly F, Konare H, Keita S, et al. Definition of an algorithm for the management of common skin diseases at primary health care level in sub-Saharan Africa. Trans R Soc Trop Med Hyg 2005;99:39-47. PMID:15550260 doi:10.1016/j.trstmh.2004.03.008 (Pubitemid 39517035)
7. The World Bank. GenderStats. Washington, DC: TWB; 2007. Available from: http://devdata.worldbank.org/AAG/sen-aag.pdf [accessed on 12 March 2009].
8. Joint United Nations Programme on HIV/AIDS. Rapport sur l'épidémie mondiale de SIDA 2004 [in French]. Geneva: UNAIDS; 2004. Available from: http://www.unaids.org/bangkok2004/ GAR2004-html-fr/ ExecSumm-fr/ExecSumm-00-fr.htm [accessed on 12 March 2009].
9. Dieng MT, Ndiaye B, Ndiaye AM. Scabies complicated by acute glomerulonephrititis in children: 114 cases observed in two years in a paediatric service in Dakar. Dakar Med 1998;43:201-4. PMID:10797963
10. Mahé A, Ly F, Aymard G, Dangou JM. Skin diseases associated with the cosmetic use of bleaching products in women from Dakar, Senegal. Br J Dermatol 2003;148:493-500. PMID:12653741 doi:10.1046/j.1365-2133.2003.05161.x (Pubitemid 36461328)
11. Grossin M. Searching for Sarcoptes. Ann Dermatol Venereol 2001;128:69-70. PMID:11226908
12. Glaziou P, Cartel JL, Alzieu P, Briot C, Moulia-Pelat JP, Martin PM. Comparison of ivermectin and benzyl benzoate for treatment of scabies. Trop Med Parasitol 1993;44:331-2. PMID:8134777 (Pubitemid 24042335)
13. Usha V, Gopalakrishnan Nair TV. A comparative study of oral ivermectin and topical permethrin cream in the treatment of scabies. J Am Acad Dermatol 2000;42:236-40. PMID:10642678 doi:10.1016/S0190-9622(00)90131-90132 (Pubitemid 30469620)
14. Chouela EN, Abeldaño AM, Pellegrano G, La Forgia M, Papale RM, Garsd A, et al. Equivalent therapeutic efficacy and safety of ivermectin and lindane in the treatment of human scabies. Arch Dermatol 1999;135:651-655 PMID:10376691 doi:10.1001/archderm.135.6.651 (Pubitemid 29277831)
15. Madan V, Jaskiran K, Gupta U, Gupta DK. Oral ivermectin in scabies patients: a comparison with 1% topical lindane solution. J Dermatol 2001;28:481-4. PMID:11603388 (Pubitemid 32958763)
16. Brooks PA, Grace RF. Ivermectin is better than benzyl benzoate for childhood scabies in developing countries. J Paediatr Child Health 2002;38:401-404 PMID:12174005 doi:10.1046/j.1440-1754.2002.00015.x (Pubitemid 35024984)
17. Nnoruka EN. Successful treatment of scabies with oral ivermectin in Nigeria. Trop Doct 2001;31:15-8. PMID:11205591 (Pubitemid 32142565)
18. Sule HM, Thacher TD. Comparison of ivermectin and benzyl benzoate lotion for scabies in Nigerian patients. Am J Trop Med Hyg 2007;76:392-5. PMID:17297053 (Pubitemid 351627790)
19. Currie BJ, Harumal P, McKinnon M, Walton SF. First documentation of in vivo and in vitro ivermectin resistance in Sarcoptes scabiei. Clin Infect Dis 2004;39:e8-12. PMID:15206075 doi:10.1086/421776
20. Diawara L. Onchocerciasis control in Senegal: evaluation of 10 years of control. Sante 1998;8:32-6. PMID:9592874
21. Haas N, Lindemann U, Frank K, Sterry W, Lademann J, Katzung W. Rapid and preferential sebum secretion of ivermectin: a new factor that may determine drug responsiveness in patients with scabies. Arch Dermatol 2002;138:1618-1619 PMID:12472363 doi:10.1001/archderm.138.12.1618 (Pubitemid 35453487)